Timothy S. Nelson's most recent trade in Impel Pharmaceuticals Inc was a trade of 13,222 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 16, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Impel Pharmaceuticals Inc | Timothy S. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2023 | 13,222 | 13,222 | - | - | Stock Option (right to buy) | |
| Impel Pharmaceuticals Inc | Timothy S. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 12,789 | 12,789 | - | - | Stock Option (right to buy) | |
| Impel Pharmaceuticals Inc | Timothy S. Nelson | Director | Purchase of securities on an exchange or from another person at price $ 10.76 per share. | 19 Nov 2021 | 10,000 | 10,000 | - | 10.8 | 107,554 | Common Stock |
| Impel Pharmaceuticals Inc | Timothy S. Nelson | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jul 2021 | 11,500 | 11,500 | - | - | Stock Option (right to buy) |